Loading…
Fierce Drug Safety Week 2021 has ended
avatar for Israel Gutierrez

Israel Gutierrez

Geron Corporation
VP of Drug Safety and Pharmacovigilance
Israel is an accomplished Global Executive with 24 years of experience building multi-therapeutic area medical affairs, clinical development, and drug safety. He has been working with multiple companies in many layers of executive management in the areas of Drug development, Risk Management, Artificial Intelligence implementation and PV Strategy. He is currently Vice President of Drug Safety and Pharmacovigilance at Geron Corp. He has provided leadership of multifunctional groups across many companies including Watosa Therapeutics,  PRA Health Sciences,  Vicapsys, Pharmacyclics, Abbvie, Exelixis,  Genentech, Roche Ltd, Celgene, Pharmion Corp, Neurosystec,  Myriad Pharmaceuticals, and Encore Pharma Inc. He is a physician and surgeon from Universidad Autonoma de Guadalajara, Science Fellow in Cardiology and Endocrinology from University of Southern California (USC).  He is a Fellow of the Royal Society of Public Health in London, and a Fellow of the Royal Society of Medicine.

My Speakers Sessions

Friday, January 22
 

1:00pm EST